Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Histopathologic changes in the uterus, cervix and vagina of immature CD-1 mice exposed to low doses of perfluorooctanoic acid (PFOA) in a uterotrophic assay.

Dixon D, Reed CE, Moore AB, Gibbs-Flournoy EA, Hines EP, Wallace EA, Stanko JP, Lu Y, Jefferson WN, Newbold RR, Fenton SE.

Reprod Toxicol. 2012 Jul;33(4):506-12. doi: 10.1016/j.reprotox.2011.10.011. Epub 2011 Nov 28.

2.

Comparative in vivo and in vitro analysis of possible estrogenic effects of perfluorooctanoic acid.

Yao PL, Ehresman DJ, Rae JM, Chang SC, Frame SR, Butenhoff JL, Kennedy GL, Peters JM.

Toxicology. 2014 Dec 4;326:62-73. doi: 10.1016/j.tox.2014.10.008. Epub 2014 Oct 18.

PMID:
25456267
3.

Prenatal perfluorooctanoic acid exposure in CD-1 mice: low-dose developmental effects and internal dosimetry.

Macon MB, Villanueva LR, Tatum-Gibbs K, Zehr RD, Strynar MJ, Stanko JP, White SS, Helfant L, Fenton SE.

Toxicol Sci. 2011 Jul;122(1):134-45. doi: 10.1093/toxsci/kfr076. Epub 2011 Apr 11.

4.

The estrogenic effects of apigenin, phloretin and myricetin based on uterotrophic assay in immature Wistar albino rats.

Barlas N, Özer S, Karabulut G.

Toxicol Lett. 2014 Apr 7;226(1):35-42. doi: 10.1016/j.toxlet.2014.01.030. Epub 2014 Jan 30.

PMID:
24487097
6.

Comparative estrogenic effects of p-nonylphenol by 3-day uterotrophic assay and female pubertal onset assay.

Kim HS, Shin JH, Moon HJ, Kang IH, Kim TS, Kim IY, Seok JH, Pyo MY, Han SY.

Reprod Toxicol. 2002 May-Jun;16(3):259-68.

PMID:
12128099
7.

Proteomic analysis of mouse testis reveals perfluorooctanoic acid-induced reproductive dysfunction via direct disturbance of testicular steroidogenic machinery.

Zhang H, Lu Y, Luo B, Yan S, Guo X, Dai J.

J Proteome Res. 2014 Jul 3;13(7):3370-85. doi: 10.1021/pr500228d. Epub 2014 Jun 25.

PMID:
24940614
8.

Validation study of OECD rodent uterotrophic assay for the assessment of estrogenic activity in Sprague-Dawley immature female rats.

Kim HS, Kang TS, Kang IH, Kim TS, Moon HJ, Kim IY, Ki H, Park KL, Lee BM, Yoo SD, Han SY.

J Toxicol Environ Health A. 2005 Dec 10;68(23-24):2249-62.

PMID:
16326438
10.

Hepatic Mitochondrial Alteration in CD-1 Mice Associated with Prenatal Exposures to Low Doses of Perfluorooctanoic Acid (PFOA).

Quist EM, Filgo AJ, Cummings CA, Kissling GE, Hoenerhoff MJ, Fenton SE.

Toxicol Pathol. 2015 Jun;43(4):546-57. doi: 10.1177/0192623314551841. Epub 2014 Oct 16.

11.

Purified methoxychlor stimulates the reproductive tract in immature female mice.

Walters LM, Rourke AW, Eroschenko VP.

Reprod Toxicol. 1993 Nov-Dec;7(6):599-606.

PMID:
8118110
12.

Analysis of PFOA in dosed CD-1 mice. Part 2. Disposition of PFOA in tissues and fluids from pregnant and lactating mice and their pups.

Fenton SE, Reiner JL, Nakayama SF, Delinsky AD, Stanko JP, Hines EP, White SS, Lindstrom AB, Strynar MJ, Petropoulou SS.

Reprod Toxicol. 2009 Jun;27(3-4):365-72. doi: 10.1016/j.reprotox.2009.02.012. Epub 2009 Mar 9.

13.

The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure.

Tucker DK, Macon MB, Strynar MJ, Dagnino S, Andersen E, Fenton SE.

Reprod Toxicol. 2015 Jul;54:26-36. doi: 10.1016/j.reprotox.2014.12.002. Epub 2014 Dec 12.

PMID:
25499722
14.

Endocrine-related effects of perfluorooctanoic acid (PFOA) in zebrafish, H295R steroidogenesis and receptor reporter gene assays.

Du G, Huang H, Hu J, Qin Y, Wu D, Song L, Xia Y, Wang X.

Chemosphere. 2013 May;91(8):1099-106. doi: 10.1016/j.chemosphere.2013.01.012. Epub 2013 Feb 8.

PMID:
23399300
15.

[Potential endocrine disrupting effects of bifenthrin in rats].

Tan Y, Wang H, Song Y, Yang H, Jia X, Li N.

Wei Sheng Yan Jiu. 2012 May;41(3):399-404. Chinese.

PMID:
23050436
16.

[Study on the estrogenic effects of isoflavone].

Zhang W, Li N, Li R.

Wei Sheng Yan Jiu. 2008 Nov;37(6):707-9. Chinese.

PMID:
19239007
17.

In utero exposure to perfluorooctanoate (PFOA) or perfluorooctane sulfonate (PFOS) did not increase body weight or intestinal tumorigenesis in multiple intestinal neoplasia (Min/+) mice.

Ngo HT, Hetland RB, Sabaredzovic A, Haug LS, Steffensen IL.

Environ Res. 2014 Jul;132:251-63. doi: 10.1016/j.envres.2014.03.033. Epub 2014 May 13.

PMID:
24834819
18.

Gestational and chronic low-dose PFOA exposures and mammary gland growth and differentiation in three generations of CD-1 mice.

White SS, Stanko JP, Kato K, Calafat AM, Hines EP, Fenton SE.

Environ Health Perspect. 2011 Aug;119(8):1070-6. doi: 10.1289/ehp.1002741. Epub 2011 Apr 18.

19.

Comparative responses of three rat strains (DA/Han, Sprague-Dawley and Wistar) to treatment with environmental estrogens.

Diel P, Schmidt S, Vollmer G, Janning P, Upmeier A, Michna H, Bolt HM, Degen GH.

Arch Toxicol. 2004 Apr;78(4):183-93. Epub 2003 Dec 20.

PMID:
14689164
20.

Weak estrogenic activity of lindane in rats.

Raizada RB, Misra P, Saxena P, Datta KK, Dikshith TS.

J Toxicol Environ Health. 1980 May;6(3):483-92.

PMID:
6158575
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk